3-Amino-2-methylpropanoic acid
| Code | Size | Price |
|---|
| TAR-T4887-100mg | 100mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T4887-1mL | 1 mL * 10 mM (in DMSO) | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
beta-aminoisobutyric acid is the product from the conversion of N-carbamyl-beta-aminoisobutyric acid by the enzyme Beta-ureidopropionase (EC 3.5.1.6), the last step in pyrimidine degradation. Beta-ureidopropionase deficiency is an inborn error of pyrimidine degradation associated with neurological abnormalities.
CAS:
144-90-1
Formula:
C4H9NO2
Molecular Weight:
103.121
Pathway:
Metabolism
Purity:
0.98
SMILES:
CC(CN)C(O)=O
Target:
Endogenous Metabolite
References
Leblanc J . Nutritional implications of cephalic phase thermogenic responses[J]. 2000, 34(2):0-216.
Kuilenburg A B P V , Meinsma R , Beke E , et al. beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities.[J]. Human Molecular Genetics, 2004, 13(22):2793-2801.
Nelson, C. P . Functional Selectivity of Muscarinic Receptor Antagonists for Inhibition of M3-Mediated Phosphoinositide Responses in Guinea Pig Urinary Bladder and Submandibular Salivary Gland[J]. Journal of Pharmacology and Experimental Therapeutics, 2004, 310(3):1255-1265.
Fornai, M. Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice[J]. Gut, 2005, 54(5):608-616.
Hu J , Dechon J , Yan K C , et al. Iptakalim inhibits nicotinic acetylcholine receptor-mediated currents in dopamine neurons acutely dissociated from rat substantia nigra pars compacta.[J]. Neuroscience Letters, 2006, 403(1):57-62.